{"id":680901,"date":"2023-12-12T18:42:01","date_gmt":"2023-12-12T18:42:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=680901"},"modified":"2023-12-12T18:42:01","modified_gmt":"2023-12-12T18:42:01","slug":"diagnostic-electrocardiograph-market-worth-113-billion-by-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/diagnostic-electrocardiograph-market-worth-113-billion-by-2028_680901.html","title":{"rendered":"Diagnostic Electrocardiograph Market worth $11.3 billion by 2028"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1702360894.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Diagnostic Electrocardiograph Market worth $11.3 billion by 2028\" src=\"https:\/\/www.abnewswire.com\/uploads\/1702360894.jpeg\" alt=\"Diagnostic Electrocardiograph Market worth $11.3 billion by 2028\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Diagnostic Electrocardiograph (ECG) Market in terms of revenue was estimated to be worth $8.1 billion in 2023 and is poised to reach $11.3 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028 according to a new report by MarketsandMarkets\u2122<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">In the near future, the Diagnostic Electrocardiograph (ECG) industry is poised to undergo a transformative evolution driven by rapid advancements in technology and healthcare integration.<\/div>\n<p style=\"text-align: justify;\"><strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/Diagnostic-ECG-global-Market-173.html?utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\" target=\"_blank\">Diagnostic Electrocardiograph (ECG) Market<\/a><\/strong>&nbsp;in terms of revenue was estimated to be worth&nbsp;$8.1 billion&nbsp;in 2023 and is poised to reach&nbsp;$11.3 billion&nbsp;by 2028, growing at a CAGR of 6.9% from 2023 to 2028 according to a new report by MarketsandMarkets&trade;. Increasing incidence of cardiovascular and lifestyle diseases, growing demand for the early and continuous diagnosis, rising aging population with heart conditions and technological advancements in wearable ECG devices are expected to support the diagnostic ECG market growth.<\/p>\n<p style=\"text-align: justify;\"><strong>Download an Illustrative overview:&nbsp;<a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=173&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=173<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Diagnostic ECG devices segment is expected to account for the largest share in 2022.<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on product type, the diagnostic ECG market is segmented into devices and software and services. The devices segment accounted for the largest share of diagnostic ECG market in 2022 owing to the increasing application of diagnostic ECG devices in the management of cardiovascular disease and&nbsp; growing presence of wide range of cost-effective ECG devices in the market<\/p>\n<p style=\"text-align: justify;\"><strong>The 12-lead segment held the largest market share in the Diagnostic Electrocardiogram (ECG) market.<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG attributed to clarity obtained by using 12 lead providing detailed outlook, making the interpretation of cardiac activity easier.<\/p>\n<p style=\"text-align: justify;\"><strong>The hospitals, clinics, and Cardiac Centers segment dominated the Diagnostic Electrocardiogram (ECG) market in 2022.<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the growing incidence of cardiovascular diseases, rising number of hospitals &amp; cardiac centers, and increase in the patient visits to physician offices for the diagnosis of CVDs.<\/p>\n<p style=\"text-align: justify;\"><strong>North America&nbsp;dominates the global Diagnostic Electrocardiogram (ECG) market<\/strong><\/p>\n<p style=\"text-align: justify;\">Based on the region segmentation, the Diagnostic Electrocardiogram (ECG) market is divided into&nbsp;North America,&nbsp;Europe,&nbsp;Asia Pacific,&nbsp;Latin America, and Middle East Africa.&nbsp;North America&nbsp;holds the largest share and expects to dominate the Diagnostic Electrocardiogram (ECG) market. The large share of the North American market can be attributed to the increasing healthcare spending, rising incidence of CVD, and rapid adoption of technologically advanced ECG devices in the region.<\/p>\n<p style=\"text-align: justify;\">The&nbsp;Asia Pacific&nbsp;is estimated to be the fastest-growing regional market for Diagnostic Electrocardiogram (ECG) products during the forecast period. The high growth in this market can be attributed to the rising proportion of population with cardiovascular diseases, rapid adoption of sedentary lifestyle, growth in aging population, and rising healthcare infrastructure.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages:&nbsp;<a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=173&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=173<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Diagnostic Electrocardiograph (ECG) Market&nbsp;Dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Drivers:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Increasing prevalence of lifestyle and cardiovascular disease<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Restraints:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Dearth of skilled professionals<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Opportunities:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Emerging markets to offer high-growth opportunities<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Challenges:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Stringent regulatory requirements delaying approval of cardiac devices<\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><strong>Key Market Players:<\/strong><\/p>\n<p style=\"text-align: justify;\">Major players in the Diagnostic Electrocardiogram (ECG) market include GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), and Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), among others<\/p>\n<p style=\"text-align: justify;\"><strong>Get 10% Free Customization on this Report:&nbsp;<a href=\"https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=173&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=173<\/a><\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=diagnostic-electrocardiograph-market-worth-113-billion-by-2028\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/Diagnostic-ECG-global-Market-173.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/Diagnostic-ECG-global-Market-173.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/Diagnostic-ECG-global-Market-173.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=diagnostic-electrocardiograph-market-worth-113-billion-by-2028\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diagnostic Electrocardiograph (ECG) Market in terms of revenue was estimated to be worth $8.1 billion in 2023 and is poised to reach $11.3 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028 according to a new &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/diagnostic-electrocardiograph-market-worth-113-billion-by-2028_680901.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-680901","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=680901"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/680901\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=680901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=680901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=680901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}